DekaBank Deutsche Girozentrale - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$211,000
-42.0%
36,2000.0%0.00%0.0%
Q2 2021$364,000
+2.5%
36,2000.0%0.00%0.0%
Q1 2021$355,000
-35.1%
36,2000.0%0.00%
-50.0%
Q4 2020$547,000
+6.2%
36,2000.0%0.00%0.0%
Q3 2020$515,000
+219.9%
36,200
+120.7%
0.00%
+100.0%
Q3 2019$161,000
-19.9%
16,400
-50.0%
0.00%0.0%
Q2 2019$201,000
-52.0%
32,800
+65.7%
0.00%
-50.0%
Q1 2019$419,000
+175.7%
19,800
+20.7%
0.00%
+100.0%
Q4 2018$152,000
-63.7%
16,400
-17.2%
0.00%
-50.0%
Q3 2018$419,000
+21.8%
19,800
-2.5%
0.00%0.0%
Q2 2018$344,000
+27.9%
20,3000.0%0.00%0.0%
Q1 2018$269,000
+100.7%
20,300
+31.0%
0.00%0.0%
Q1 2016$134,000
-44.9%
15,500
-14.8%
0.00%
-33.3%
Q4 2015$243,000
+27.9%
18,200
+1.1%
0.00%
+50.0%
Q3 2015$190,000
-59.7%
18,000
+4.0%
0.00%
-66.7%
Q2 2015$471,000
-7.8%
17,300
+3.6%
0.01%0.0%
Q1 2015$511,00016,7000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders